Trial Outcomes & Findings for The Utility of Telemedicine in the Management of Migraine (NCT NCT01706003)

NCT ID: NCT01706003

Last Updated: 2019-10-25

Results Overview

Percentage of completed scheduled study visits for each group.

Recruitment status

COMPLETED

Target enrollment

45 participants

Primary outcome timeframe

One Year

Results posted on

2019-10-25

Participant Flow

Participant milestones

Participant milestones
Measure
In-Office Group
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated in the clinician's office for migraine headaches
Telemedicine Group
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated via telemedicine for migraine headaches
Overall Study
STARTED
23
22
Overall Study
COMPLETED
12
18
Overall Study
NOT COMPLETED
11
4

Reasons for withdrawal

Reasons for withdrawal
Measure
In-Office Group
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated in the clinician's office for migraine headaches
Telemedicine Group
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated via telemedicine for migraine headaches
Overall Study
Withdrawal by Subject
2
0
Overall Study
Not scheduled
3
0
Overall Study
Lost to Follow-up
6
4

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
In-Office Group
n=23 Participants
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated in the clinician's office for migraine headaches
Telemedicine Group
n=22 Participants
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated via telemedicine for migraine headaches
Total
n=45 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=23 Participants
0 Participants
n=22 Participants
0 Participants
n=45 Participants
Age, Categorical
Between 18 and 65 years
23 Participants
n=23 Participants
22 Participants
n=22 Participants
45 Participants
n=45 Participants
Age, Categorical
>=65 years
0 Participants
n=23 Participants
0 Participants
n=22 Participants
0 Participants
n=45 Participants
Sex: Female, Male
Female
21 Participants
n=23 Participants
22 Participants
n=22 Participants
43 Participants
n=45 Participants
Sex: Female, Male
Male
2 Participants
n=23 Participants
0 Participants
n=22 Participants
2 Participants
n=45 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
23 participants
n=23 Participants
22 participants
n=22 Participants
45 participants
n=45 Participants
Migraine Disability Assessment Score (MIDAS)
40.5 units on a scale
n=23 Participants
65 units on a scale
n=22 Participants
47.9 units on a scale
n=45 Participants

PRIMARY outcome

Timeframe: One Year

Percentage of completed scheduled study visits for each group.

Outcome measures

Outcome measures
Measure
In-Office Group
n=12 Participants
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated in the clinician's office for migraine headaches
Telemedicine Group
n=18 Participants
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated via telemedicine for migraine headaches
Assess the Utility of Telemedicine for Follow-up Care in a Headache Medicine Practice
87 percentage of scheduled appointments
92.7 percentage of scheduled appointments

Adverse Events

In-Office Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Telemedicine Group

Serious events: 3 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
In-Office Group
n=23 participants at risk
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated in the clinician's office for migraine headaches
Telemedicine Group
n=22 participants at risk
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated via telemedicine for migraine headaches
Nervous system disorders
Hospital admission
0.00%
0/23 • 1 year
13.6%
3/22 • Number of events 5 • 1 year

Other adverse events

Adverse event data not reported

Additional Information

Deborah I. Friedman, MD, MPH, Professor of Neurology and Neurotherapeutics and Ophthalmology

UT Southwestern Medical Center

Phone: 2146483517

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place